Antabio on quest to tackle antibiotic resistance
26 May 2023 //
CLINICAL TRIALS ARENA
Antabio Announces First Subjects Dosed in Phase 1 Clinical Trial of MEM-ANT3310
25 May 2023 //
GLOBENEWSWIRE
Antabio Receives QIDP Designation From the USFDA for the Dev of MEM-ANT3310
05 May 2020 //
PR NEWSWIRE